Select Page

Selbyville, Delaware, Sept. 14, 2020 (GLOBE NEWSWIRE) — According to MarketStudyReport LLC, reliable estimates, global cancer biomarkers market was valued at USD 10.9 billion in 2019 and is predicted to grow with a CAGR of 11.8% over 2020-2027. Rising incidences of cancer, increasing awareness regarding cancer therapy among patients, and surging government & private funding towards development of cancer biomarkers are impelling the industry growth, claims the report. In fact, as stated by the World Health Organization (WHO), cancer is the second major cause of fatalities globally and was responsible for nearly 70% of deaths in developed and developing countries in 2018.As per the given report, global cancer biomarkers market is scrutinized based on application scope, cancer type, profiling technology, biomolecule class, and regional terrain. Detailed analysis of changing industry dynamics with respect to major competitors as well as a detailed overview of the segments and sub-segments are provided in the document.
For the record, cancer biomarker is a traceable substance that indicates the existence of cancerous cells in human body. Swift treatment results can be attained by examining cancer biomarkers using different diagnostic techniques that help in preventing and detecting cancer, hence stimulating product popularity.  
As per International Agency for Research on Cancer (IARC), there were 9.6 million cancer deaths among 18.1 million novel cases of cancer reported globally in 2018. The report further projects that by 2040, approximately 27.5 million new cancer cases and 16.3 million cancer deaths will be registered. Improving awareness regarding benefits of early diagnosis and emphasis on controlling cancer cases worldwide will provide impetus to cancer biomarkers market size.Request Sample copy of this Report @ the downside, high cost of vaccine development and unregulated government norms & reimbursement policies are likely to restrain global cancer biomarkers market growth during 2020-2027.Elaborating market segmentations:Based on profiling technology, global cancer biomarkers market is segmented into omic technologies, immunoassays, imaging technologies, and cytogenetics-based tests. With respect to biomolecule class, the industry is divided into protein, genetic, and glyco-biomarkers.Speaking of cancer type, global cancer biomarkers market is classified into stomach cancer, breast cancer, colorectal cancer, lung cancer, prostate cancer, and others. With regards to applications spectrum, the market is bifurcated into prognostics, diagnostics, risk assessment, drug discovery & development, and others.Considering regional overviewGlobal cancer biomarkers industry landscape is fragmented into Asia Pacific, Europe, North America, Latin America and rest of the world. North America accounted for majority industry share in the recent past, owing to increasing utilization of cancer biomarkers in drug discovery & development as well as dense presence of industry players in the region.Meanwhile, Asia-Pacific cancer biomarkers market is expected to showcase strong growth trends during 2020-2027, due to ever-rising cancer cases and improving healthcare infrastructure in emerging nations such as China and India.To access a sample copy or view this report in detail along with the table of contents, please click the link below: Cancer Biomarkers Market Application Analysis (Revenue, USD Billion, 2017-2027)Risk AssessmentDiagnosticsPrognosticsDrug Discovery & DevelopmentOthersGlobal Cancer Biomarkers Market Cancer Type Analysis (Revenue, USD Billion, 2017-2027)Breast CancerStomach CancerLung CancerProstate CancerColorectal CancerOthersGlobal Cancer Biomarkers Market Biomolecule Analysis (Revenue, USD Billion, 2017-2027)Glyco-biomarkersProtein BiomarkersGenetic BiomarkersGlobal Cancer Biomarkers Market Profiling Technology Analysis (Revenue, USD Billion, 2017-2027)Omic TechnologiesImmunoassaysImaging TechnologiesCytogenetics-based TestsGlobal Cancer Biomarkers Market Regional Analysis (Revenue, USD Billion, 2017-2027)North AmericaCanadaU.S.EuropeItalyFranceGermanyUKSpainRest of EuropeAsia PacificJapanSouth KoreaChinaIndiaAustraliaRest of Asia PacificLatin AmericaBrazilMexicoRest of the WorldGlobal Cancer Biomarkers Market Competitive Landscape Analysis (Revenue, USD Billion, 2017-2027)PerkinElmer Inc.Abbott LaboratoriesQiagen N.V.Bristol-Myers Squibb CompanyExact Sciences CorporationBio-Rad Laboratories Inc.F. Hoffmann-La Roche Ltd.Siemens AGMerck KGaAThermo Fisher Scientific Inc.Table of Content:Chapter 1. Executive Summary1.1.         Market Snapshot1.2.         Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)1.2.1.     Cancer Biomarkers Market, by Region, 2018-2027 (USD Billion)1.2.2.     Cancer Biomarkers Market, by Profiling Technology, 2018-2027 (USD Billion)1.2.3.     Cancer Biomarkers Market, by Biomolecule, 2018-2027 (USD Billion)1.2.4.     Cancer Biomarkers Market, by Cancer Type, 2018-2027 (USD Billion)1.2.5.     Cancer Biomarkers Market, by Application, 2018-2027 (USD Billion)1.3.         Key Trends1.4.         Estimation Methodology1.5.         Research AssumptionChapter 2.  Global Cancer Biomarkers Market Definition and Scope2.1.         Objective of the Study2.2.         Market Definition & Scope2.2.1.     Scope of the Study2.2.2.     Industry Evolution2.3.         Years Considered for the Study2.4.         Currency Conversion RatesChapter 3.  Global Cancer Biomarkers Market Dynamics              3.1.         Cancer Biomarkers Market Impact Analysis (2018-2027)3.1.1.     Market Drivers3.1.2.     Market Challenges3.1.3.     Market OpportunitiesChapter 4.  Global Cancer Biomarkers Market: Industry Analysis4.1.         Porter’s five Force Model4.2.         PEST Analysis4.2.1.     Political4.2.2.     Economical4.2.3.     Social4.2.4.     Technological4.3.         Investment Adoption Model4.4.         Analyst Recommendation & ConclusionChapter 5. Global Cancer Biomarkers Market, by Profiling Technology5.1.         Market Snapshot5.2.         Global Cancer Biomarkers Market by Profiling Technology, Performance – Potential Analysis5.3.         Global Cancer Biomarkers Market Estimates & Forecasts by Profiling Technology 2017-2027 (USD Billion)5.4.         Cancer Biomarkers Market, Sub Segment Analysis5.4.1.     Omic Technologies5.4.2.     Imaging Technologies5.4.3.     Immunoassays5.4.4.     Cytogenetics-based TestsChapter 6. Global Cancer Biomarkers Market, by Biomolecule6.1.         Market Snapshot6.2.         Global Cancer Biomarkers Market by Biomolecule, Performance – Potential Analysis6.3.         Global Cancer Biomarkers Market Estimates & Forecasts by Biomolecule 2017-2027 (USD Billion)6.4.         Cancer Biomarkers Market, Sub Segment Analysis6.4.1.     Genetic Biomarkers6.4.2.     Protein Biomarkers6.4.3.     Glyco-biomarkersChapter 7. Global Cancer Biomarkers Market, by Cancer Type         7.1.         Market Snapshot7.2.         Global Cancer Biomarkers Market by Cancer Type, Performance – Potential Analysis7.3.         Global Cancer Biomarkers Market Estimates & Forecasts by Cancer Type 2017-2027 (USD Billion)7.4.         Cancer Biomarkers Market, Sub Segment Analysis7.4.1.     Breast Cancer7.4.2.     Lung Cancer7.4.3.     Colorectal Cancer7.4.4.     Prostate Cancer7.4.5.     Stomach Cancer7.4.6.     OthersChapter 8. Global Cancer Biomarkers Market, by Application8.1.         Market Snapshot8.2.         Global Cancer Biomarkers Market by Application – Potential Analysis8.3.         Global Cancer Biomarkers Market Estimates & Forecasts by Application 2017-2027 (USD Billion)8.4.         Cancer Biomarkers Market, Sub Segment Analysis8.4.1.     Diagnostics8.4.2.     Drug Discovery and Development8.4.3.     Prognostics8.4.4.     Risk Assessment8.4.5.     OthersChapter 9. Global Cancer Biomarkers Market, Regional AnalysisRelated Report:Cancer Diagnostics Market Research Report 2019 to 2025